Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
Radoslaw Kaczmarek, Researcher at IU School of Medicine and Hirszfeld Institute, shared an insightful review on X, reposting from The Video Journal of Hematology and Hematological Oncology:
”Thank you for having me The Video Journal of Hematology and Hematological Oncology.
Several colleagues and I also published a reflective article on this:
I summarized some key points in the video.
SPOILER ALERT
It is not due to lack of interest in gene therapy.”
Read the full article here.
Article: Why is the uptake of gene therapy in hemophilia less than expected?
Authors: Glenn F. Pierce, Mark Skinner, Brian O’Mahony, Dawn Rotellini, Radoslaw Kaczmarek
The Video Journal of Hematology and Hematological Oncology shared on X:
”Why has the uptake of gene therapy in hemophilia been less than expected? Is there limited interest in these therapies?
We caught up with Radoslaw Kaczmarek of Indiana University School of Medicine to get the answers to these questions.”
Watch the full interview.
Stay informed on all scientific advances in the field of genetics with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t